Displaying drugs 1376 - 1400 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Indacaterol | 392.4907 C24H28N2O3 |  | An inhaled long-acting beta-2 adrenergic agonist used to relax bronchial smooth muscle and improve symptoms and airflow obstruction caused by Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma. | Agents producing tachycardia / Agents that produce hypertension |
| Erdosteine | 249.307 C8H11NO4S2 |  | A mucolytic agent used to treat conditions characterized by pathological mucus such as respiratory tract infections and chronic obstructive pulmonary disease (COPD). | Expectorants |
| Ganaxolone | 332.528 C22H36O2 |  | A neuroactive steroid GABA-A receptor modulator used for the treatment of seizures associated with CDKL5 deficiency disorder (CDD). | GABA Modulators / Neurotransmitter Agents |
| Trabectedin | 761.837 C39H43N3O11S |  | An alkylating agent approved for the treatment of unresectable or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma). | Alkylating Drugs / Antineoplastic Agents, Alkylating / Dioxoles / Tetrahydroisoquinolines |
| Pretomanid | 359.2574 C14H12F3N3O5 |  | Part of a three-drug regimen used for the treatment of extensively drug-resistant and multidrug-resistant pulmonary tuberculosis. | Drugs for Treatment of Tuberculosis |
| Crisaborole | 251.05 C14H10BNO3 |  | A non-steroidal topical medication used for the treatment of mild-moderate atopic dermatitis. | Agents for Dermatitis, Excluding Corticosteroids |
| Cobimetinib | 531.318 C21H21F3IN3O2 |  | An antineoplastic agent and selective inhibitor of the mitogen-activated extracellular kinase (MEK) pathway used to treat unresectable or metastatic melanoma. | Mitogen-activated protein kinase (MEK) inhibitors / Protein Kinase Inhibitors |
| Silver sulfadiazine | 357.137 C10H9AgN4O2S |  | A topical sulfonamide antibiotic that acts on the bacterial cell wall and cell membrane; approved for the treatment of burns. | Sulfonamides |
| Methsuximide | 203.2371 C12H13NO2 |  | A succinimide anticonvulsant that increases the seizure threshold. Primarily used for childhood absence seizures. Functions by suppressing paroxysmal spike-and-wave patterns associated with lapses of consciousness in absence seizures. | Succinimide Derivatives |
| Gallium nitrate | 255.738 GaN3O9 |  | A drug previously indicated to treat cancer-related hypercalcemia. | Antineoplastic Agents / Calcium Resorption Inhibitor / Calcium-Regulating Hormones and Agents / Immunosuppressive Agents |
| Rotigotine | 315.48 C19H25NOS |  | A non-selective dopamine agonist used for the treatment of Parkinson's Disease and Restless Leg Syndrome. | Agents that produce hypertension / Dopamine Agents |
| Samarium (153Sm) lexidronam | 586.021 C6H17N2O12P4Sm |  | A chelated complex of samarium isotope and EDTMP that concentrates in areas with high bone turnover such as sites of metastases to relieve pain associated with osteoblastic metastatic bone lesions. | Various Pain Palliation Radiopharmaceuticals |
| Vandetanib | 475.354 C22H24BrFN4O2 |  | An antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. | Protein Kinase Inhibitors |
| Pimavanserin | 427.564 C25H34FN3O2 |  | A second generation atypical antipsychotic used for the treatment of hallucinations and delusions caused by Parkinson's Disease. | Neurotoxic agents |
| Dexlansoprazole | 369.36 C16H14F3N3O2S |  | A proton pump inhibitor used to treat erosive esophagitis, heartburn, and gastroesophageal reflux disease (GERD). | Anti-Ulcer Agents / Proton Pump Inhibitors |
| Histamine | 111.1451 C5H9N3 |  | An ingredient of topical drugs for the relief of joint pain or muscle aches and pains. | Tests for Gastric Secretion |
| Iodine | 253.8089 I2 |  | An ingredient of nutritional supplements that is also used for disinfection. | Iodine Products |
| Tetrachlorodecaoxide | 319.821 Cl4H2O11 |  | Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, cancer/tumors (unspecified), HIV infection, and inflammatory disorders (unspecified). | Radiation-Protective Agents |
| Palovarotene | 414.549 C27H30N2O2 |  | A selective agonist of retinoic acid receptor gamma (RARĪ³) used to reduce heterotopic ossification in patients with Fibrodysplasia Ossificans Progressiva (FOP). | BCRP/ABCG2 Inhibitors / Benzene Derivatives / Benzylidene Compounds / BSEP/ABCB11 Inhibitors / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / Musculo-Skeletal System / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / OCT1 inhibitors / Retinoids |
| Telaprevir | 679.8493 C36H53N7O6 |  | An NS3/4A viral protease inhibitor used in combination with other antivirals for the curative treatment of chronic Hepatitis C Virus infections. | Antivirals for treatment of HCV infections / Protease Inhibitors |
| Brivaracetam | 212.2887 C11H20N2O2 |  | An anticonvulsant used for the treatment of partial-onset seizures that functions by binding to synaptic vesicle glycoprotein 2A (SV2A) in the brain. | Anticonvulsants / Central Nervous System Agents / Central Nervous System Depressants / Cytochrome P-450 CYP2B6 Substrates / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Epoxide Hydrolase Inhibitors / Miscellaneous Anticonvulsants / Nervous System / Pyrrolidines |
| Sodium stibogluconate | 907.88 C12H35Na3O26Sb2 |  | For the treatment of various types of a protozoal infection called leishmaniasis, which may result from sandfly bites in tropical and temperate parts of the world. Also investigated for use/treatment... | Antimony Compounds |
| Levoketoconazole | 531.431 C26H28Cl2N4O4 |  | One of two enantiomeric forms of racemic ketoconazole that strongly inhibits multiple steroidogenic enzymes and is used for the symptomatic treatment of endogenous Cushing's syndrome. | Anticorticosteroids |
| Apremilast | 460.5 C22H24N2O7S |  | A non-steroidal medication used for the treatment of inflammatory conditions such as psoriasis and psoriatic arthritis. | Selective Immunosuppressants |
| Abiraterone | 349.509 C24H31NO |  | An antiandrogen used in the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer. | Androstenes / Antineoplastic Agents / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P450 17A1 Inhibitors / Steroid Synthesis Inhibitors |
Displaying drugs 1376 - 1400 of 2774 in total